Literature DB >> 26758685

AMPKγ3 is dispensable for skeletal muscle hypertrophy induced by functional overload.

Isabelle Riedl1, Megan E Osler1, Marie Björnholm1, Brendan Egan2, Gustavo A Nader3, Alexander V Chibalin1, Juleen R Zierath4.   

Abstract

Mechanisms regulating skeletal muscle growth involve a balance between the activity of serine/threonine protein kinases, including the mammalian target of rapamycin (mTOR) and 5'-AMP-activated protein kinase (AMPK). The contribution of different AMPK subunits to the regulation of cell growth size remains inadequately characterized. Using AMPKγ3 mutant-overexpressing transgenic Tg-Prkag3(225Q) and AMPKγ3-knockout (Prkag3(-/-)) mice, we investigated the requirement for the AMPKγ3 isoform in functional overload-induced muscle hypertrophy. Although the genetic disruption of the γ3 isoform did not impair muscle growth, control sham-operated AMPKγ3-transgenic mice displayed heavier plantaris muscles in response to overload hypertrophy and underwent smaller mass gain and lower Igf1 expression compared with wild-type littermates. The mTOR signaling pathway was upregulated with functional overload but unchanged between genetically modified animals and wild-type littermates. Differences in AMPK-related signaling pathways between transgenic, knockout, and wild-type mice did not impact muscle hypertrophy. Glycogen content was increased following overload in wild-type mice. In conclusion, our functional, transcriptional, and signaling data provide evidence against the involvement of the AMPKγ3 isoform in the regulation of skeletal muscle hypertrophy. Thus, the AMPKγ3 isoform is dispensable for functional overload-induced muscle growth. Mechanical loading can override signaling pathways that act as negative effectors of mTOR signaling and consequently promote skeletal muscle hypertrophy.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  AMP-activated protein kinase-γ3

Mesh:

Substances:

Year:  2016        PMID: 26758685      PMCID: PMC4796264          DOI: 10.1152/ajpendo.00387.2015

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  40 in total

1.  Diminished overload-induced hypertrophy in aged fast-twitch skeletal muscle is associated with AMPK hyperphosphorylation.

Authors:  David M Thomson; Scott E Gordon
Journal:  J Appl Physiol (1985)       Date:  2004-10-01

2.  5'-AMP-activated protein kinase regulates skeletal muscle glycogen content and ergogenics.

Authors:  Brian R Barnes; Stephan Glund; Yun Chau Long; Göran Hjälm; Leif Andersson; Juleen R Zierath
Journal:  FASEB J       Date:  2005-05       Impact factor: 5.191

3.  Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.

Authors:  Masaaki Komatsu; Satoshi Waguri; Masato Koike; Yu-Shin Sou; Takashi Ueno; Taichi Hara; Noboru Mizushima; Jun-Ichi Iwata; Junji Ezaki; Shigeo Murata; Jun Hamazaki; Yasumasa Nishito; Shun-Ichiro Iemura; Tohru Natsume; Toru Yanagawa; Junya Uwayama; Eiji Warabi; Hiroshi Yoshida; Tetsuro Ishii; Akira Kobayashi; Masayuki Yamamoto; Zhenyu Yue; Yasuo Uchiyama; Eiki Kominami; Keiji Tanaka
Journal:  Cell       Date:  2007-12-14       Impact factor: 41.582

Review 4.  How to interpret LC3 immunoblotting.

Authors:  Noboru Mizushima; Tamotsu Yoshimori
Journal:  Autophagy       Date:  2007-06-19       Impact factor: 16.016

5.  Opposite transcriptional regulation in skeletal muscle of AMP-activated protein kinase gamma3 R225Q transgenic versus knock-out mice.

Authors:  Elisabeth C Nilsson; Yun Chau Long; Sofia Martinsson; Stephan Glund; Pablo Garcia-Roves; L Thomas Svensson; Leif Andersson; Juleen R Zierath; Margit Mahlapuu
Journal:  J Biol Chem       Date:  2006-01-12       Impact factor: 5.157

6.  TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

Authors:  Ken Inoki; Hongjiao Ouyang; Tianqing Zhu; Charlotta Lindvall; Yian Wang; Xiaojie Zhang; Qian Yang; Christina Bennett; Yuko Harada; Kryn Stankunas; Cun-Yu Wang; Xi He; Ormond A MacDougald; Ming You; Bart O Williams; Kun-Liang Guan
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

Review 7.  AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy.

Authors:  D Grahame Hardie
Journal:  Nat Rev Mol Cell Biol       Date:  2007-10       Impact factor: 94.444

8.  Normal hypertrophy accompanied by phosphoryation and activation of AMP-activated protein kinase alpha1 following overload in LKB1 knockout mice.

Authors:  Sean L McGee; Kirsty J Mustard; D Grahame Hardie; Keith Baar
Journal:  J Physiol       Date:  2008-01-17       Impact factor: 5.182

9.  Sarcolipin is a newly identified regulator of muscle-based thermogenesis in mammals.

Authors:  Naresh C Bal; Santosh K Maurya; Danesh H Sopariwala; Sanjaya K Sahoo; Subash C Gupta; Sana A Shaikh; Meghna Pant; Leslie A Rowland; Eric Bombardier; Sanjeewa A Goonasekera; A Russell Tupling; Jeffery D Molkentin; Muthu Periasamy
Journal:  Nat Med       Date:  2012-09-09       Impact factor: 53.440

10.  Gain-of-function R225W mutation in human AMPKgamma(3) causing increased glycogen and decreased triglyceride in skeletal muscle.

Authors:  Sheila R Costford; Nihan Kavaslar; Nadav Ahituv; Shehla N Chaudhry; Wendy S Schackwitz; Robert Dent; Len A Pennacchio; Ruth McPherson; Mary-Ellen Harper
Journal:  PLoS One       Date:  2007-09-19       Impact factor: 3.240

View more
  2 in total

1.  Human Carboxylesterase 2 Reverses Obesity-Induced Diacylglycerol Accumulation and Glucose Intolerance.

Authors:  Maxwell A Ruby; Julie Massart; Devon M Hunerdosse; Milena Schönke; Jorge C Correia; Sharon M Louie; Jorge L Ruas; Erik Näslund; Daniel K Nomura; Juleen R Zierath
Journal:  Cell Rep       Date:  2017-01-17       Impact factor: 9.423

Review 2.  AMPK in skeletal muscle function and metabolism.

Authors:  Rasmus Kjøbsted; Janne R Hingst; Joachim Fentz; Marc Foretz; Maria-Nieves Sanz; Christian Pehmøller; Michael Shum; André Marette; Remi Mounier; Jonas T Treebak; Jørgen F P Wojtaszewski; Benoit Viollet; Louise Lantier
Journal:  FASEB J       Date:  2018-01-05       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.